<DOC>
	<DOCNO>NCT01245621</DOCNO>
	<brief_summary>ENABLE III randomize clinical trial evaluate phone-based palliative care intervention design improve quality life , mood , symptom management patient advanced stage cancer caregiver . The primary aim clinical trial determine whether palliative care intervention ( introduce immediately 12 week diagnosis ) improve survival , quality life , mood , symptom intensity end-of-life care .</brief_summary>
	<brief_title>Study Palliative Care Intervention Advanced Cancer Patients Their Caregivers -Educate Nurture Advise Before Life Ends ( ENABLE III )</brief_title>
	<detailed_description>In 2008 , cancer claim 565,000 American life -1,500 people day . Palliative care strives improve quality life ( QOL ) prevent `` bad death '' provide expert , interdisciplinary care manage effect disease treatment . Effective end-of-life ( EOL ) care depend upon proactive , patient-centered intervention prepare patient family challenge terminal illness . We able demonstrate feasibility efficacy concurrent oncology palliative care ( COPC ) intervention improve quality life mood previous study ENABLE I ENABLE II ; however , number gap knowledge remain . Patients randomize begin intervention either immediately 12 week new diagnosis advance recurrent cancer . This phone-based intervention consist : 1 ) Advanced Practice Palliative Care Nurse Interventionist institute 1a ) 6-session manualized patient curriculum- Charting Your Course ( CYC ) , 1b ) 3-session manualized , caregiver curriculum- Creativity Optimism Planning Expert information ( COPE ) program , 1c ) on-going patient caregiver follow ; 2 ) Palliative Care Team Comprehensive Assessment &amp; Management .</detailed_description>
	<mesh_term>Neoplasms</mesh_term>
	<criteria>INCLUSION CRITERIA FOR PATIENTS : 1 . Able speak understand English 2 . Over age 18 3 . NEW diagnosis , recurrence , progression advance stage cancer within THIRTY day date patient inform diagnosis his/her oncology clinician . 4 . Estimated survival 2 year less 5 . Diagnosed advanced stage cancer one following : Lung Cancer : Stage IIIB IV nonsmall cell , extensive stage small cell Breast Cancer : Stage IV poor prognostic indicator include limited : ) &gt; 2 cytotoxic regimen MBC ; b ) diagnosis MBC le equal 12 month since completion adjuvant neoadjuvant treatment ; c ) triple negative disease ( ER/PR Her 2 ) ; ) parenchymal brain mets and/or carcinomatous meningitis Gastrointestinal ( GI ) Cancers : Unresectable stage III IV Genitourinary ( GU ) Cancers : Stage IV ( prostate cancer inclusion limit person hormone refractory prostate cancer ) Brain Cancer : Unresectable , Grade IV Melanoma , Stage IV Hematologic Malignancies Leukemia ( e.g . acute myeloid leukemia ( AML ) , acute lymphoblastic leukemia ( ALL ) , chronic myeloid leukemia ( CML ) , chronic lymphocytic leukemia ( CLL ) advance stage , treatment refractory , poor prognosis cell type chromosomal abnormality , `` old age '' Lymphoma Stage IV treatment refractory Hodgkin 's disease nonHodgkin 's lymphoma Multiple Myeloma elevate β2microglobulin , albumin &lt; 3.5 , PCLI &gt; 1 % , CRP &gt; 6µg/mL , elevate LDH , plasmablastic morphology , abnormal . chromosome 13 . 6 . Completion baseline interview INCLUSION CRITERIA FOR PATIENTS FOR BIOMARKER SUBSTUDY : 1 . Only patient lung , breast , GI , GU cancer eligible INCLUSION CRITERIA FOR CAREGIVERS : 1 . Able read understand English 2 . Anyone identify patient `` person know well &amp; involve medical care '' . PATIENT EXCLUSION CRITERIA : 1 . Dementia significant confusion ( Impaired cognitive status indicate score 3 less Callahan sixitem cognitive screen tool 18 ) 2 . Axis I psychiatric diagnosis severe mental illness ( DSMIV ) ( e.g . schizophrenia , bipolar disorder , active substance use disorder ) 3 . Patients exclude identify caregiver 4 . Prior involvement palliative care service within last year 5 . Minimum predict survival le 12 week ( 3 month ) PATIENT BIOMARKER SUBSTUDY EXCLUSION CRITERIA : 1 . Receiving chronic steroid hormone unable schedule specimen collection distant chemotherapy steroid premedications 2 . Unable come Norris Cotton Cancer Center ( NCCC ) specimen collection time . CAREGIVER EXCLUSION CRITERIA : 1 . Unwilling participate study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2013</verification_date>
	<keyword>palliative care</keyword>
	<keyword>end life care</keyword>
	<keyword>quality life</keyword>
	<keyword>caregiver</keyword>
</DOC>